IAMA Therapeutics
- Website
- iamatherapeutics.com
- Total Funding
- $17.5M
- Last Round
- $17.5M Venture RoundApr 2025
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
IAMA Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule medicines for central nervous system disorders. It combines neuroscience drug discovery and precision medicine to develop therapies including selective NKCC1 inhibitors intended to restore inhibitory neurotransmission and rebalance neuronal excitability. The company develops treatments for neurological conditions including drug-resistant epilepsy and autism spectrum disorders.
Summary
IAMA Therapeutics is a Biotech company. It has raised $17.5M in total across 1 round, most recently a $17.5M Venture Round in Apr 2025. Investors include Indaco Venture Partners.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/iama-therapeutics"><img src="https://indexed.vc/api/badge/company/iama-therapeutics" alt="IAMA Therapeutics on Indexed.vc" width="260" height="76" /></a>